Patent details

Basic Information

Publication number:

EP3272362

PCT Application Number:

JP2016058455

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167650571

PCT Publication Number:

WO2016148228

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION

French Title of Invention:

COMPOSITION PHARMACEUTIQUE À LIBÉRATION PROLONGÉE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT VERZÖGERTER FREISETZUNG

SPC Number:

Dates

Filing date:

17/03/2016

Grant date:

13/12/2023

EP Publication Date:

24/01/2018

PCT Publication Date:

22/09/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/12/2023

EP B1 Publication Date:

13/12/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/03/2024

Expiration date:

17/03/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/12/2023

 

 

Name:

Santen Pharmaceutical Co., Ltd.

Address:

9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku Osaka-shi Osaka 533-8651, Japan (JP)

Inventor

1

Name:

FUJISAWA, Toyomi

Address:

Japan (JP)

2

Name:

YAMADA, Kazuhito

Address:

Japan (JP)

3

Name:

OKABE, Komei

Address:

Japan (JP)

Priority

Priority Number:

2015055196

Priority Date:

18/03/2015

Priority Country:

Japan (JP)

Classification

IPC classification:

A61K 47/14; A61K 31/444; A61K 47/10; A61K 47/20; A61K 47/34; A61P 27/02;

Publication

European Patent Bulletin

Issue number:

202350

Publication date:

13/12/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages